Ben Lamm

Colossal Announces $7.5M in New Investments in Ancient DNA Academic Research

by | Apr 17, 2024
Colossal Biosciences’ academic investments include partnerships with Stockholm University, the University of Potsdam, the University of California Santa Cruz, the University of Alaska, McMaster University, University of Copenhagen, and Rowan University, among others.
MORE
Colossal Biosciences Adds Renowned Ancient DNA Expert as Chief Science Officer
by | Mar 19, 2024
Dallas-based Colossal said that in her new role, MacArthur Award winner Beth Shapiro will oversee continued expansion of the company's de-extinction and conservation science teams. The company previously announced plans to "de-extinct" the woolly mammoth, the Tasmanian tiger, and the dodo bird.
MORE
Director of Oscar-Winning ‘My Octopus Teacher’ To Make a Docuseries on Dallas-Based Colossal Biosciences
by | Feb 21, 2024
Colossal Biosciences and production partner Teton Ridge Entertainment have signed with James Reed, director of the Oscar-winning Netflix documentary "My Octopus Teacher," and his company Underdog Films, to produce the docuseries.
MORE
Hollywood Brand Veteran Takes CMO Helm at Colossal Biosciences to Bring De-Extinction to the Global Stage
by | Feb 2, 2024

Veteran marketing executive Emily Castel has joined Colossal Bioscience, the world’s first de-extinction company, as its first chief marketing officer, bringing her global entertainment and consumer brand experience to Colossal where she will lead global efforts to scale the company’s brand, experiences, consumer products, and emerging media properties....

MORE

Colossal Partners with Mauritian Wildlife Foundation To ‘Rewild’ the Dodo, as Another Bird Gets a ‘Genetic Rescue’

by | Nov 27, 2023
“The dodo is the symbol of man-caused extinction,” Dallas-based Colossal Co-Founder and CEO Ben Lamm said last January. “It’s only fitting that Colossal works to reverse that.” The newly announced partnership with the MWF could help advance Colossal's efforts by restoring the dodo's natural habitat.
MORE
Here Be Dragons: Colossal Partners with Zoos Victoria To Save Reptile Once Thought Extinct
by | Oct 25, 2023
OK, it may not be as big—or as fire-breathing—as the dragons that swooped over Westeros on "Game of Thrones." But Australia's Victorian Grassland Earless Dragon is every bit as magical for simply hanging in there, decades after many thought it was extinct. Now Texas-based Colossal Biosciences is partnering to help preserve it—and sequence its genome.
MORE
Meet the Finalists: The Innovation Awards 2024, Presented by Dallas Innovates and D CEO
by | Oct 13, 2023

Dallas Innovates and D CEO are proud to announce the finalists for its fifth annual Innovation Awards. The program honors companies, CEOs, CIOS, CTOs, entrepreneurs, and other leaders who are helping to make Dallas-Fort Worth an innovation hub....

MORE
Ben Lamm Hypergiant

The Last Word: Dallas Serial Entrepreneur Ben Lamm Exits Another Company

by | Aug 22, 2023
Dating apps can be a great way to find romance. But increasingly, according to the Wall Street Journal, users are finding something else instead: business come-ons from tech recruiters, networkers, children's book authors, and more.
MORE
Meet the North Texas Cos. on the 2023 TIME100 Most Influential List
by | Jun 21, 2023
Featuring "a diverse group of businesses helping chart an essential path forward," the TIME100 Most Influential Companies list features five companies that are either headquartered in North Texas or have a strong presence here. See who they are—and what they're doing to disrupt the status quo and innovate for the future.
MORE
Colossal Biosciences, Vertebrate Genomes Project Publish First High-Quality Reference Genome of African Elephant
by | May 19, 2023
Last year, the partnership announced a near complete sequence of the Asian elephant genome. Colossal and VGP said the sequencing work is part of a long-term effort to ensure the survival of elephant species in the face of climate change, deforestation, and disease.
MORE

Texas-Based Colossal Achieves Unicorn Status With $150M Series B Raise, Plans To ‘De-Extinct’ the Dodo Bird

by | Jan 31, 2023
Colossal says its efforts could help boost "the U.S. high-tech advantage." Its gene editing technologies "will make waves across sectors—in agriculture with new biofuels and preserving biodiversity, as well as in human health through improved gene therapy and vaccine development," the company said.
MORE
Here Are the Winners of The Innovation Awards 2023
by | Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District. Here's a full list of winners and finalists.
MORE
Meet the Finalists: The Innovation Awards 2023, Presented by Dallas Innovates and D CEO
by | Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas. Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE
Mammoth Interest: The CIA Invests in Dallas-Based Colossal Biosciences
by | Oct 11, 2022
The Central Intelligence Agency has invested in Colossal through its nonprofit VC investment arm, In-Q-Tel, reports The Intercept. Named in honor of Q—the tech genius from the James Bond novels and movies—the VC firm was founded in 1999 to keep U.S. intelligence agencies on the cutting edge of "innovative and impactful technologies coming out of Silicon Valley and beyond." So why Colossal? "Strategically, it’s less about the mammoths and more about the capability," In-Q-Tel says.
MORE